Literature DB >> 9438603

Hereditary pancreatitis and familial pancreatic cancer.

M D Finch1, N Howes, I Ellis, R Mountford, R Sutton, M Raraty, J P Neoptolemos.   

Abstract

Important advances in the understanding of pancreatic diseases have taken place through the application of molecular methods in the study of the inherited form of pancreatitis and pancreas cancer. Mutations of the cationic trypsinogen gene have been found to be causative for hereditary pancreatitis with important implications for the molecular pathogenesis of acute and chronic pancreatitis. A variety of cancer syndromes involving the P16 and BRCA2 genes, for example, also lead to pancreatic cancer, but the gene responsible for familial pancreatic cancer has not been identified so far. The establishment of a European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC) will facilitate future developments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9438603     DOI: 10.1159/000201502

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  A new polymorphism for the RI22H mutation in hereditary pancreatitis.

Authors:  N Howes; W Greenhalf; S Rutherford; M O'Donnell; R Mountford; I Ellis; D Whitcomb; C Imrie; B Drumm; J P Neoptolemos
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

3.  CDKN2A germline mutations in familial pancreatic cancer.

Authors:  Detlef K Bartsch; Mercedes Sina-Frey; Sven Lang; Anja Wild; Berthold Gerdes; Peter Barth; Ralf Kress; Robert Grützmann; Mario Colombo-Benkmann; Andreas Ziegler; Stephan A Hahn; Matthias Rothmund; Harald Rieder
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

4.  The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease.

Authors:  J Threadgold; W Greenhalf; I Ellis; N Howes; M M Lerch; P Simon; J Jansen; R Charnley; R Laugier; L Frulloni; A Oláh; M Delhaye; I Ihse; O B Schaffalitzky de Muckadell; A Andrén-Sandberg; C W Imrie; J Martinek; T M Gress; R Mountford; D Whitcomb; J P Neoptolemos
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 5.  [Hereditary pancreatic cancer].

Authors:  N Habbe; P Langer; D K Bartsch
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

Review 6.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

Review 7.  Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancer.

Authors:  Gabriele Lami; Maria Rosa Biagini; Andrea Galli
Journal:  World J Gastrointest Endosc       Date:  2014-07-16

Review 8.  Current approaches to novel therapeutics in pancreatic cancer.

Authors:  Corina E Akerele; Irina Rybalova; Howard L Kaufman; Sridhar Mani
Journal:  Invest New Drugs       Date:  2003-02       Impact factor: 3.850

9.  The role of tobacco-derived carcinogens in pancreas cancer.

Authors:  Rajiv Lochan; Helen L Reeves; Anne K Daly; Richard M Charnley
Journal:  ISRN Oncol       Date:  2011-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.